Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Mol Cell Neurosci. 2011 Jun 12;48(1):29–37. doi: 10.1016/j.mcn.2011.06.002

Figure 4.

Figure 4

A. MN9D cells treated with 2 mM db-cAMP and immunostained with an antibody against β-III tubulin show extension of neurites characteristic of the differentiated state. Bar = 40 μm. B. Western blot of pTH, total TH, and α-synuclein in MN9D cells treated with db-cAMP for 48 to 96 h. β-actin was used as a loading control. C. α-synuclein mRNA from MN9D cells treated 48 or 96 h with 2 mM db-cAMP